Tower Research Capital LLC (TRC) - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$4,000
-60.0%
30,130
-36.8%
0.00%
-100.0%
Q3 2016$10,000
+233.3%
47,677
+274.5%
0.00%
Q2 2016$3,000
+200.0%
12,732
+274.6%
0.00%
Q1 2016$1,000
-50.0%
3,399
-21.0%
0.00%
Q4 2015$2,0004,300
+3881.5%
0.00%
Q3 2015$0108
-55.6%
0.00%
Q2 2015$0243
-40.0%
0.00%
Q1 2015$0
-100.0%
405
-73.4%
0.00%
Q4 2014$1,000
-66.7%
1,524
-59.5%
0.00%
Q3 2014$3,000
-25.0%
3,766
-17.5%
0.00%
-100.0%
Q2 2014$4,000
+100.0%
4,566
+109.7%
0.00%
Q1 2014$2,0002,1770.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Northeast Financial Consultants Inc 150,000$109,0000.05%
CONDOR CAPITAL MANAGEMENT 211,371$154,0000.04%
Benin Management CORP 83,000$61,0000.03%
First Heartland Consultants, Inc. 20,000$15,0000.01%
Advisory Services Network, LLC 22,000$16,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,000$131,0000.00%
Moors & Cabot, Inc. 11,000$7,0000.00%
TCI Wealth Advisors, Inc. 3,000$2,0000.00%
Corbenic Partners LLC 1,600$1,0000.00%
WFG Advisors, LP 3,500$3,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders